Safety, tolerability and efficacy of agonist anti-CD27 antibody (varlilumab) administered in combination with anti-PD-1 (nivolumab) in advanced solid tumors
激动剂抗CD27抗体(varlilumab)与抗PD-1抗体(nivolumab)联合治疗晚期实体瘤的安全性、耐受性和疗效
期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2022-005147
Sanborn, Rachel E; Pishvaian, Michael J; Callahan, Margaret K; Weise, Amy; Sikic, Branimir I; Rahma, Osama; Cho, Daniel C; Rizvi, Naiyer A; Sznol, Mario; Lutzky, Jose; Bauman, Julie E; Bitting, Rhonda L; Starodub, Alexander; Jimeno, Antonio; Reardon, David A; Kaley, Thomas; Iwamoto, Fabio; Baehring, Joachim M; Subramaniam, Deepa S; Aragon-Ching, Jeanny B; Hawthorne, Thomas R; Rawls, Tracey; Yellin, Michael; Keler, Tibor